Pharminent

Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass.

LEXINGTON, Massachusetts, November 22, 2016 /PRNewswire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that it will expand its operations in Cambridge, Massachusetts, establishing a rare disease innovation hub and increasing its footprint in the heart of Kendall Square. Shire… http://www.prnewswire.com/news-releases/shire-to-establish-rare-disease-innovation-hub-in-cambridge-mass-602419365.html

Filed under: Company